Morihito Okada
#143,895
Most Influential Person Now
Researcher
Morihito Okada's AcademicInfluence.com Rankings
Morihito Okadacomputer-science Degrees
Computer Science
#7082
World Rank
#7459
Historical Rank
Computational Linguistics
#1351
World Rank
#1366
Historical Rank
Machine Learning
#2503
World Rank
#2536
Historical Rank
Artificial Intelligence
#2792
World Rank
#2836
Historical Rank
Download Badge
Computer Science
Morihito Okada's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Morihito Okada Influential?
(Suggest an Edit or Addition)Morihito Okada's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. (2009) (3910)
- Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. (2006) (622)
- Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. (2019) (540)
- A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). (2010) (479)
- Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial. (2019) (378)
- Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. (2005) (317)
- Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? (2001) (289)
- Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE) (2020) (274)
- Functional advantage after radical segmentectomy versus lobectomy for lung cancer. (2005) (260)
- Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial. (2019) (241)
- Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy. (2014) (240)
- A novel video-assisted anatomic segmentectomy technique: selective segmental inflation via bronchofiberoptic jet followed by cautery cutting. (2007) (209)
- Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. (2012) (183)
- Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy. (2000) (168)
- Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. (2004) (168)
- Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial (2022) (164)
- Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. (2013) (157)
- Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT) (2019) (156)
- Complex permittivities of breast tumor tissues obtained from cancer surgeries (2014) (147)
- Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. (1998) (131)
- Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. (2006) (127)
- Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. (2011) (118)
- Operative approach for multiple primary lung carcinomas. (1998) (115)
- Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. (2012) (111)
- Pleomorphic carcinoma of the lung: a surgical outcome. (2007) (106)
- Extended sleeve lobectomy for lung cancer: the avoidance of pneumonectomy. (1999) (102)
- Prognosis of completely resected pN2 non-small cell lung carcinomas: What is the significant node that affects survival? (1999) (101)
- Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. (2004) (99)
- Hybrid surgical approach of video-assisted minithoracotomy for lung cancer: significance of direct visualization on quality of surgery. (2005) (98)
- The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling (2019) (93)
- Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer (2009) (90)
- Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension (2003) (86)
- Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings. (2013) (85)
- A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study) (2016) (85)
- Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age. (2005) (85)
- Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma (2010) (83)
- Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. (2007) (80)
- Detectability of Breast Tumor by a Hand-held Impulse-Radar Detector: Performance Evaluation and Pilot Clinical Study (2017) (75)
- Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis. (1999) (74)
- The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma. (2013) (74)
- Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection. (2004) (73)
- Thoracic and cardiovascular surgery in Japan in 2016 (2019) (72)
- Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis. (2006) (71)
- Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis. (2010) (70)
- Resection of chest wall invasion in patients with non-small cell lung cancer. (2004) (70)
- Expression of the TSLC1 Adhesion Molecule in Pulmonary Epithelium and Its Down-Regulation in Pulmonary Adenocarcinoma Other than Bronchioloalveolar Carcinoma (2003) (65)
- Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review. (2017) (65)
- Radical surgery for malignant pleural mesothelioma: results and prognosis. (2008) (65)
- Thoracic and cardiovascular surgeries in Japan during 2017 (2020) (63)
- Utility of 18F FDG-PET/CT for predicting prognosis of luminal-type breast cancer (2015) (63)
- Pleural lavage cytology in non-small cell lung cancer: lessons from 1000 consecutive resections. (2003) (61)
- Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma. (2015) (61)
- Illustrated Anatomical Segmentectomy for Lung Cancer (2012) (61)
- Phase III study comparing bevacizumab plus erlotinib to erlotinib in patients with untreated NSCLC harboring activating EGFR mutations: NEJ026. (2018) (59)
- Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma. (2003) (58)
- Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung. (2011) (57)
- Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung (2003) (57)
- Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study (2013) (57)
- Role of pleural lavage cytology before resection for primary lung carcinoma. (1999) (56)
- Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis (2018) (56)
- Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma. (2013) (54)
- Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma. (2003) (54)
- Surgical Outcomes of Complex Versus Simple Segmentectomy for Stage I Non-Small Cell Lung Cancer. (2019) (53)
- NEJ026: Final overall survival analysis of bevacizumab plus erlotinib treatment for NSCLC patients harboring activating EGFR-mutations. (2020) (52)
- Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer. (2019) (52)
- Radical hybrid video-assisted thoracic segmentectomy: long-term results of minimally invasive anatomical sublobar resection for treating lung cancer. (2012) (50)
- Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial) (2015) (50)
- Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. (2004) (49)
- Thoracic and cardiovascular surgery in Japan during 2015 (2018) (47)
- Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma. (2016) (47)
- Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer (2017) (46)
- Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma. (2014) (46)
- How should interlobar pleural invasion be classified? Prognosis of resected T3 non-small cell lung cancer. (1999) (45)
- Upregulation of Notch2 and Six1 Is Associated with Progression of Early-Stage Lung Adenocarcinoma and a More Aggressive Phenotype at Advanced Stages (2011) (44)
- Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014–2015† (2017) (44)
- Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer. (2019) (44)
- Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. (2005) (43)
- Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma. (2013) (42)
- Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer. (2013) (42)
- Biological Effects of Low-Dose Chest CT on Chromosomal DNA. (2020) (39)
- Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy. (2016) (39)
- A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413). (2018) (37)
- Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications. (2014) (37)
- Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma. (2016) (37)
- Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations. (2000) (36)
- Thoracic and cardiovascular surgeries in Japan during 2018 (2020) (36)
- Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical Stage I non-small-cell lung cancer (2018) (36)
- Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer. (2015) (35)
- Esophageal reconstruction using the terminal ileum and right colon in esophageal cancer surgery (2012) (35)
- Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma. (2016) (35)
- Outcomes after lobar versus sublobar resection for clinical stage I non−small cell lung cancer in patients with interstitial lung disease (2017) (34)
- Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial. (2021) (34)
- Bevacizumab beyond disease progression after first‐line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non–small cell lung cancer (West Japan Oncology Group 5910L): An open‐label, randomized, phase 2 trial (2016) (34)
- Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema (2013) (33)
- Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer? (2019) (32)
- Rapamycin enhances chemotherapy‐induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells (2010) (32)
- Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging. (2014) (32)
- Cloning of a soluble isoform of the SgIGSF adhesion molecule that binds the extracellular domain of the membrane-bound isoform (2004) (32)
- Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma. (2014) (32)
- Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non–Small-Cell Lung Cancer With EGFR Mutation (IMPACT) (2021) (31)
- Short disease‐free interval is a significant risk factor for intrapulmonary recurrence after resection of pulmonary metastases in colorectal cancer (2009) (31)
- Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology. (2014) (31)
- Subtyping lung adenocarcinoma according to the novel 2011 IASLC/ATS/ERS classification: correlation with patient prognosis. (2013) (31)
- Krebs von den Lungen‐6 (KL‐6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer (2011) (29)
- Expression of cell adhesion molecule 1 in malignant pleural mesothelioma as a cause of efficient adhesion and growth on mesothelium (2008) (29)
- Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer. (2009) (28)
- Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma (2017) (27)
- A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303 (2018) (27)
- Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer. (2016) (27)
- Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer (2017) (26)
- Treatment Outcomes and Prognostic Factors After Recurrence of Esophageal Squamous Cell carcinoma (2018) (26)
- Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer. (2015) (26)
- Initial results of robot-assisted thoracoscopic surgery in Japan (2014) (25)
- Sleeve segmentectomy for non-small cell lung carcinoma. (2004) (25)
- Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil (2012) (25)
- The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial. (2015) (25)
- MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma (2017) (25)
- Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer (2012) (24)
- Hemoglobin Level Influences Tumor Response and Survival After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (2014) (24)
- Novel marker D2‐40, combined with calretinin, CEA, and TTF‐1 (2007) (23)
- Involvement of homologous recombination in the synergism between cisplatin and poly (ADP‐ribose) polymerase inhibition (2013) (23)
- Role of 18F‐PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy (2017) (23)
- Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer. (2014) (23)
- Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma (2019) (22)
- Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis. (2020) (22)
- Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells (2012) (21)
- Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma. (2021) (21)
- Radical sublobar resection for lung cancer (2008) (21)
- Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets (2017) (21)
- α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma (2014) (20)
- Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery (2018) (20)
- Surgical Outcomes of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema (2015) (19)
- Prediction of lymph node status in clinical stage IA squamous cell carcinoma of the lung. (2015) (19)
- MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung (2018) (19)
- Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma. (2013) (19)
- Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles (2020) (19)
- Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report (2012) (19)
- Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma† (2016) (19)
- Wnt5a-induced cell migration is associated with the aggressiveness of estrogen receptor-positive breast cancer (2018) (19)
- Esophageal bypass operation prior to definitive chemoradiotherapy in advanced esophageal cancer with tracheobronchial invasion. (2014) (19)
- Randomized Phase II Study of Adjuvant Chemotherapy with Long-term S-1 versus Cisplatin+S-1 in Completely Resected Stage II–IIIA Non–Small Cell Lung Cancer (2015) (19)
- Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma (2018) (19)
- Inhibition of PAI‐1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer‐associated fibroblasts (2019) (18)
- Airway stenting for malignant respiratory complications in esophageal cancer. (2012) (18)
- Detectability of Breast Tumors in Excised Breast Tissues of Total Mastectomy by IR-UWB-Radar-Based Breast Cancer Detector (2019) (18)
- Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer. (2009) (18)
- Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma. (2015) (18)
- Completion lobectomy after radical segmentectomy for pulmonary malignancies (2016) (18)
- Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer (2012) (18)
- Albumin–globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer (2019) (17)
- Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma (2019) (17)
- A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma. (2008) (17)
- Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy. (2019) (17)
- Treatment outcomes and prognostic factors for thoracic esophageal cancer with clinical evidence of adjacent organ invasion. (2013) (17)
- Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3) (2020) (17)
- Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection? (2017) (16)
- What are the radiologic findings predictive of indolent lung adenocarcinoma? (2015) (16)
- Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206. (2020) (16)
- Clinicopathologic Features and Response to Therapy of NRG1 Fusion–Driven Lung Cancers: The eNRGy1 Global Multicenter Registry (2021) (16)
- Increased risk of recurrence in resected EGFR‐positive pN0M0 invasive lung adenocarcinoma (2018) (16)
- Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma (2017) (16)
- MA 19.01 A Phase II Study of Nivolumab: A Multicenter, Open-Label, Single Arm Study in Malignant Pleural Mesothelioma (MERIT) (2017) (16)
- Steroid receptor expression in thymomas and thymic carcinomas (2011) (16)
- A randomised phase II trial of preoperative chemotherapy of cisplatin–docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) (2008) (16)
- Segmentectomy Versus Lobectomy for Radiologically Pure Solid Clinical T1a-bN0M0 Lung Cancer (2018) (16)
- Predicting Severe Postoperative Complication in Patients with Lung Cancer and Interstitial Pneumonia. (2019) (16)
- Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line. (2008) (15)
- Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma (2018) (15)
- Risk assessments for broncho-pleural fistula and respiratory failure after lung cancer surgery by National Clinical Database Japan (2018) (15)
- Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer. (2020) (15)
- Technical feasibility and cosmetic advantage of hybrid endoscopy-assisted breast-conserving surgery for breast cancer patients. (2013) (15)
- Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma (2020) (15)
- Memorial Sloan-Kettering Cancer Center Nomogram to predict the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients (2012) (15)
- Prediction of biological characteristics of breast cancer using dual-phase FDG PET/CT (2019) (15)
- Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment. (2021) (15)
- Management pathways for solitary pulmonary nodules. (2018) (15)
- Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303 (2021) (15)
- Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer (2015) (14)
- Novel application for pseudopodia proteomics using excimer laser ablation and two-dimensional difference gel electrophoresis (2012) (14)
- Portable impulse-radar detector for breast cancer: a pilot study (2018) (14)
- A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil‐Tegafur as the Adjuvant Chemotherapy in Resected Non–Small Cell Lung Cancer (2018) (14)
- Comparing Segmentectomy and Lobectomy for Clinical Stage IA Solid-dominant Lung Cancer Measuring 2.1 to 3 cm. (2020) (14)
- Histologic changes associated with the use of fibrinogen- and thrombin-impregnated collagen in the prevention of pulmonary air leakage. (2015) (14)
- Classifications of n2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes. (2013) (14)
- Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I non–small cell lung cancer (2013) (14)
- High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data from JCOG0201. (2019) (14)
- Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes. (2015) (13)
- Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer. (2017) (13)
- Prospective, randomized, cross-over pilot study of the effects of Rikkunshito, a Japanese traditional herbal medicine, on anorexia and plasma-acylated ghrelin levels in lung cancer patients undergoing cisplatin-based chemotherapy (2019) (13)
- Radical sublobar resection for small-diameter lung cancers. (2013) (13)
- Traditional Japanese herbal medicine rikkunshito increases food intake and plasma acylated ghrelin levels in patients with esophageal cancer treated by cisplatin-based chemotherapy. (2019) (13)
- Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. (2012) (13)
- Evaluation of Malignancy Grade of Breast Cancer Using Perflubutane-Enhanced Ultrasonography. (2016) (13)
- Prediction of lymph node metastasis using semiquantitative evaluation of PET for lung adenocarcinoma. (2020) (13)
- Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study. (2018) (13)
- Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy (2018) (12)
- Surgical treatment of clinical N1 non-small cell lung cancer: Ongoing controversy over diagnosis and prognosis (2010) (12)
- Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer. (2019) (12)
- Two cases of synchronous multiple thymoma (1998) (12)
- Guanylate binding protein 1 (GBP-1) promotes cell motility and invasiveness of lung adenocarcinoma. (2019) (12)
- Successful management of multiple esophagorespiratory fistulas using two types of stent: Report of a case (2011) (12)
- Fibrinogen/thrombin-based collagen fleece (TachoComb(R)) promotes regeneration in pulmonary arterial injury. (2012) (12)
- Utility of Newly Proposed Grading System From International Association for the Study of Lung Cancer for Invasive Lung Adenocarcinoma (2020) (12)
- Identification of Axillary Lymph Node Metastasis in Patients With Breast Cancer Using Dual-Phase FDG PET/CT. (2019) (12)
- Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma (2019) (11)
- Induction of γδT Cells Using Zoledronate Plus Interleukin-2 in Patients with Metastatic Cancer (2009) (11)
- Breast cancer cell motility is promoted by 14-3-3γ (2019) (11)
- Nivolumab versus chemotherapy in advanced esophageal squamous cell carcinoma (ESCC): The phase III ATTRACTION-3 study (2019) (11)
- Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma (2016) (11)
- Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study (2020) (11)
- Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma. (2015) (11)
- Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis: a phase III study evaluating survival (JCOG1708, SURPRISE). (2020) (11)
- Increased ectodomain shedding of cell adhesion molecule 1 as a cause of type II alveolar epithelial cell apoptosis in patients with idiopathic interstitial pneumonia (2015) (11)
- Solid tumor size of 2 cm divides outcomes of patients with mixed ground glass opacity lung tumors. (2020) (11)
- The intracellular domain of cell adhesion molecule 1 is present in emphysematous lungs and induces lung epithelial cell apoptosis (2015) (11)
- A Two-Stage Rotational Surface Clutter Suppression Method for Microwave Breast Imaging With Multistatic Impulse-Radar Detector (2020) (11)
- Which type of breast cancers is undetectable on ring-type dedicated breast PET? (2018) (11)
- Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy. (2014) (11)
- Cathepsin D as a potential prognostic marker for lung adenocarcinoma. (2012) (11)
- Adjuvant gefitinib versus cisplatin/vinorelbine in Japanese patients with completely resected, EGFR-mutated, stage II-III non-small cell lung cancer (IMPACT, WJOG6410L): A randomized phase 3 trial. (2021) (11)
- Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer (2019) (10)
- Salvage surgery for non-small-cell lung cancer after definitive radiotherapy. (2020) (10)
- Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy (2020) (10)
- Laparoscopic thoracic duct clipping for persistent chylothorax after extrapleural pneumonectomy. (2012) (10)
- Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma (2018) (10)
- Methylated DLX4 Predicts Response to Pathologic Stage I Non-Small Cell Lung Cancer Resection. (2015) (10)
- Segmentectomy vs. lobectomy for clinical stage IA lung adenocarcinoma with spread through air spaces. (2020) (10)
- Surgical treatment for chronic pleural empyema (2010) (10)
- Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy (2020) (10)
- Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non–small cell lung cancer (WJOG 5910L): An open-label, randomized, phase II trial. (2015) (10)
- Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer (2018) (10)
- Three-Year Follow-Up and Response–Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3) (2022) (9)
- Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma. (2017) (9)
- Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion. (2008) (9)
- Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing (2017) (9)
- Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer. (2020) (9)
- Tumor-infiltrating Lymphocyte Score Based on FDG PET/CT for Predicting the Effect of Neoadjuvant Chemotherapy in Breast Cancer (2020) (9)
- Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma. (2017) (9)
- Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study. (2016) (9)
- Severity of lung fibrosis affects early surgical outcomes of lung cancer among patients with combined pulmonary fibrosis and emphysema (2016) (9)
- A phase II study of nivolumab: a multicenter, open-label, single arm study in malignant pleural mesothelioma (MERIT). (2018) (9)
- Prolonged post-recurrence survival following pleurectomy/decortication for malignant pleural mesothelioma. (2019) (9)
- A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707) (2020) (9)
- The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer (2019) (9)
- Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy (2020) (9)
- Clinical and molecular features of rapidly progressive chronic hypersensitivity pneumonitis (2017) (9)
- Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component (2019) (8)
- Adjuvant chemotherapy for pathological stage I non-small cell lung cancer with high-risk factors for recurrence: A multicenter study. (2019) (8)
- A Feasibility Study of Postoperative Adjuvant Therapy of Carboplatin and Weekly Paclitaxel for Completely Resected Non-small Cell Lung Cancer (2008) (8)
- Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients (2014) (8)
- Involvement of ribonucleotide reductase-M1 in 5-fluorouracil‑induced DNA damage in esophageal cancer cell lines. (2013) (8)
- A feasibility study of induction pemetrexed plus cisplatin followed by pleurectomy/decortication aimed at macroscopic complete resection for malignant pleural mesothelioma. (2013) (8)
- Wedge resection as an alternative treatment for octogenarian and older patients with early-stage non-small-cell lung cancer. (2020) (8)
- Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia (2018) (8)
- A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer (2011) (8)
- Synchronicity of genetic variants between primary sites and metastatic lymph nodes, and prognostic impact in nodal metastatic lung adenocarcinoma (2019) (8)
- Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study (2018) (8)
- Advantage of absorbable suture material for pulmonary artery ligation (2010) (8)
- Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients (2017) (8)
- Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer (2021) (8)
- Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus (2018) (8)
- Use of entecavir to prevent hepatitis B virus reactivation during cytotoxic chemotherapy for solid malignancy (2009) (7)
- Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer. (2020) (7)
- Skin tube reconstruction for esophageal defect due to postoperative complication. (2009) (7)
- The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study. (2021) (7)
- 1271PRANDOMIZED PHASE III STUDY COMPARING GEFITINIB (G) WITH ERLOTINIB (E) IN PATIENTS (PTS) WITH PREVIOUSLY TREATED ADVANCED LUNG ADENOCARCINOMA (LA): WJOG 5108L. (2014) (7)
- Oncologic outcomes of Complex Segmentectomy: A Multicenter Propensity Score-Matched Analysis. (2020) (7)
- Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma (2020) (7)
- Transition of Treatment for Ground Glass Opacity–Dominant Non-Small Cell Lung Cancer (2021) (7)
- Use of Anti-Noxa Antibody for Differential Diagnosis between Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia (2016) (7)
- Japanese Current Status of Curative-Intent Surgery for Malignant Pleural Mesothelioma. (2021) (7)
- Three-year follow-up of ATTRACTION-3: A phase III study of nivolumab (Nivo) in patients with advanced esophageal squamous cell carcinoma (ESCC) that is refractory or intolerant to previous chemotherapy. (2021) (7)
- Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer. (2018) (7)
- Prognosis of lung cancer patients with a past history of colorectal cancer. (2014) (6)
- Emergency escape surgery for a gastro-bronchial fistula with respiratory failure that developed after esophagectomy (2014) (6)
- Bronchoplasty for bronchial carcinoid tumor without removing lung parenchyma. (2006) (6)
- Prospective feasibility study of sealing pulmonary vessels with energy in lung surgery (2019) (6)
- Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer. (2020) (6)
- Adjuvant chemotherapy for high-risk pathological stage I non-small cell lung cancer. (2021) (6)
- Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial (WJOG 12119L). (2021) (6)
- Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid. (2012) (6)
- SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma (2020) (6)
- Current Status of Multi-modality Treatment for Malignant Pleural Mesothelioma in Japan (2008) (6)
- Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma. (2014) (6)
- Cytology of Pleural Effusion and Lavage Samples at Thoracotomy in Cases of Primary Lung Cancer. (1992) (6)
- Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling (2019) (6)
- Tumor Response in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy Followed by Surgery (2020) (6)
- Enhanced gefitinib‐induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia‐mutated kinase inhibition in non‐small‐cell lung cancer cells (2016) (6)
- Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma. (2016) (6)
- OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study) (2018) (5)
- Correction to: Thoracic and cardiovascular surgery in Japan during 2001 : Annual report by the Japanese Association for Thoracic Surgery. (2018) (5)
- Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study) (2021) (5)
- Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer (2015) (5)
- Hybrid video-assisted thoracic surgery basilar (S9-10) segmentectomy. (2011) (5)
- Initial experience of robotic anatomical segmentectomy for non-small cell lung cancer. (2020) (5)
- Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer (2021) (5)
- Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer. (2021) (5)
- Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients (2021) (5)
- The effect of rikkunshito, a traditional Japanese herbal medicine, on food intake and plasma acylated ghrelin levels in lung cancer patients treated with platinum-based chemotherapy (2016) (5)
- Postoperative Pulmonary Function After Complex Segmentectomy (2021) (5)
- Clinical Significance of 18F-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma (2019) (5)
- Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II Study (2018) (5)
- Segmentectomy Versus Lobectomy in Small-Sized Peripheral Non-Small Cell Lung Cancer (JCOG0802/WJOG4607L): A Multicentre, Randomised, Controlled, Phase 3 Trial (2021) (5)
- role of segmentectomy as a type of lesser resection Effect of tumor size on prognosis in patients with non-small cell lung cancer: The (2013) (5)
- Advanced esophageal cancer with an esophago-bronchial fistula successfully treated by chemoradiotherapy following esophageal bypass surgery: report of a case (2012) (4)
- Lung cancer risk stratification using methylation profile in the oral epithelium (2018) (4)
- General Knack of Segmentectomy (2012) (4)
- Classification of Abnormal Findings on Ring-type Dedicated Breast PET for the Detection of Breast Cancer (2020) (4)
- Prognostic impact of lymphatic invasion for pathological stage I squamous cell carcinoma of the lung (2015) (4)
- Dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in esophageal cancer patients: Correlation with clinicopathological factors and prognosis. (2008) (4)
- Suggestive synchronous triple squamous cell carcinoma of the lung in the same lobe (2010) (4)
- Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung (2021) (4)
- Bronchoplasties at the Segmental Level. (2018) (4)
- Correction to: Thoracic and cardiovascular surgery in Japan in 2016 (2019) (4)
- Investigation of surgical technique for bronchial stump closure after lobectomy in animal model (2019) (4)
- Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer (2020) (4)
- A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study) (2021) (4)
- The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303 (2022) (4)
- Lung metastasis of adenoid cystic carcinoma, which mimicked primary lung cancer (2013) (4)
- Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma (2021) (4)
- P2.06-11 A Phase I/II Study of Intrapleural Ad-SGE-REIC Administration in Patients with Refractory Malignant Pleural Mesothelioma (2018) (4)
- Simultaneous occurrence of three primary lung cancers. (1994) (4)
- Reassessment of Right Middle Lobe Lung Cancer: Comparison of Segments 4 and 5 Tumors. (2018) (4)
- Diagnostic performance of peripheral leukocyte telomere G‐tail length for detecting breast cancer (2020) (4)
- Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE (2021) (4)
- The impact of epidermal growth factor receptor mutation status on adjuvant chemotherapy for patients with high-risk stage I lung adenocarcinoma. (2022) (4)
- Descending necrotizing mediastinitis and the proposal of a new classification (2021) (4)
- Is cancer history really an exclusion criterion for clinical trial of lung cancer? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery. (2016) (4)
- Methylation of Breast Cancer Susceptibility Gene 1 (BRCA1) Predicts Recurrence in Patients With Curatively Resected Stage I Non-small Cell Lung Cancer (2012) (4)
- Lung abscess presenting as tension pyopneumothorax in a gastrointestinal cancer patient. (2014) (3)
- P2.01-97 Prognostic Factors in Resected Lung Mucinous Adenocarcinoma: Clinical and Pathological Features (2018) (3)
- Long-term results after 12-year follow-up of patients treated with whole-breast and boost irradiation after breast-conserving surgery (2016) (3)
- Airway stenting for tracheal obstruction due to lymph node metastasis of hepatocellular carcinoma. (2013) (3)
- MULTIPLE PRIMARY LUNG CARCINOMAS. AUTHORS 'REPLY (1999) (3)
- The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer (2022) (3)
- Management of air leak after pulmonary resection. (2004) (3)
- [Identification of intersegmental border in radical segmentectomy]. (2010) (3)
- Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer. (2020) (3)
- Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer (2021) (3)
- First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50) (2022) (3)
- Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer (2021) (3)
- Prognostic Impact of Mediastinal Lymph Node Dissection in Octogenarians With Lung Cancer: JACS1303. (2021) (3)
- Use of high-resolution computed tomography and positron emission tomography/computed tomography in the management of stage IA adenocarcinoma. (2012) (3)
- Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors. (2021) (3)
- [CDDP+CPT-11 therapy is useful for stage IVb esophageal small cell carcinoma]. (2009) (3)
- Appropriate Extent of Lymphadenectomy in Segmentectomy: A Multicenter Study. (2020) (3)
- Surgical outcomes of non-small-cell lung carcinoma in patients previously treated for gastric cancer. (2015) (3)
- Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma (2020) (3)
- Randomized phase III study of irinotecan/cisplatin (IP) versus etoposide/cisplatin (EP) for completely resected high-grade neuroendocrine carcinoma (HGNEC) of the lung: JCOG1205/1206. (2020) (3)
- Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer. (2021) (3)
- Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma. (2021) (3)
- Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge Resection. (2020) (3)
- Src-Homology 2 Domain-Containing Phosphatase 2 in Resected EGFR Mutation-Positive Lung Adenocarcinoma (2020) (3)
- Advanced esophageal cancer with situs inversus totalis successfully treated with chemoradiotherapy followed by esophagectomy: case report. (2011) (3)
- Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. (2012) (3)
- Significance of lung biopsy for the definitive diagnosis of lung nodules in breast cancer patients (2017) (3)
- Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer. (2015) (3)
- A CASE OF GIST OF DUODENUM SUCCESSFULLY TREATED WITH NEOADJUVANT IMATINIB AND LIMITED SURGERY (2007) (3)
- Safety and compliance data of the phase III study of adjuvant chemotherapy for patients (pts) with completely resected, pathological (p-) stage I (T1 > 2 cm) non-small cell lung cancer (NSCLC): A Japan Clinical Oncology Group Trial, JCOG0707. (2016) (3)
- Three-step surgical treatment of aortoesophageal fistula after thoracic endovascular aortic repair: A case report (2019) (3)
- Correction to: Breast cancer cell motility is promoted by 14-3-3γ (2019) (3)
- Erratum: “Complex permittivities of breast tumor tissues obtained from cancer surgeries” [Appl. Phys. Lett. 104, 253702 (2014)] (2015) (3)
- The unusual development of empyema with multiple alveolobronchiolar fistulae 8 years after non-curative resection and radiation for lung cancer: Report of a case (2004) (2)
- Comparison of Open and Thoracoscopic Esophagectomy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy (2021) (2)
- Non-small cell lung cancer, early stage (2012) (2)
- Wnt 5 a-induced cell migration is associated with the aggressiveness of estrogen receptor-positive breast cancer (2018) (2)
- Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung (2021) (2)
- The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer. (2022) (2)
- Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors (2022) (2)
- Role of soluble receptor for advanced glycation end products in postoperative fibrotic lung injury. (2021) (2)
- Prevention of Postoperative Prolonged Air Leak After Pulmonary Resection. (2020) (2)
- A phase II neoadjuvant trial of sequential triweekly nanoparticle albumin-bound paclitaxel and cyclophosphamide followed by 5-fluorouracil/epirubicin/ cyclophosphamide in the treatment of operable breast cancer. (2014) (2)
- Long-term Esophageal Cancer Survivor Treated by Bypass for Esophagobronchial Fistula After Chemoradiotherapy: A Case Report (2019) (2)
- Prediction of acute exacerbation of interstitial pneumonia using visual evaluation of PET. (2020) (2)
- Application of PET/CT to adjuvant chemotherapy for early lung adenocarcinoma (2015) (2)
- Prediction of the tumor response and survival based on computed tomography in esophageal squamous cell carcinoma after trimodality therapy (2021) (2)
- Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL) (2021) (2)
- Clinical benefit of neoadjuvant chemoradiotherapy for the avoidance of pneumonectomy; assessment in 12 consecutive centrally located non-small cell lung cancers (2017) (2)
- Cervicothoracic vagal neurilemoma: Report of a case (2006) (2)
- Prognostic impact of targetable genetic variants in resected adenocarcinoma of the lung: a narrative review and model proposal for precise evaluation (2020) (2)
- Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma. (2016) (2)
- Segmentectomy of the Left Lower Lobe (2012) (2)
- Complete transection of the left main bronchus caused by blunt thoracic trauma in a child treated by bronchoplasty and lung parenchyma preservation (2016) (2)
- Expression of orotate phosphoribosyltransferase in colorectal carcinoma: an immunohistochemical analysis in several components of neoplastic lesions. (2008) (2)
- Association between [ 18 F ]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1 α and glucose transporter 1 in non-small cell lung cancer (2015) (2)
- P2.14-52 The Results from Plasma EGFR Mutation Analysis in NEJ026 Study (2019) (2)
- Long-term outcomes after sublobar resection for clinical stage IA lung adenocarcinoma meeting node-negative criteria defined by HRCT and FDG-PET/CT. (2018) (2)
- 1895MO Three-year follow-up results of the MERIT trial: A Japanese phase II study of nivolumab in malignant pleural mesothelioma (2020) (2)
- Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography. (2021) (2)
- Can PET/CT substitute for bone scintigraphy in assessment of bone metastases in lung cancer patients? (2016) (2)
- Segmentectomy of the Right Upper Lobe (2012) (2)
- Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE) (2022) (2)
- Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinoma (2021) (1)
- Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer (2022) (1)
- Abstract P1-02-11: Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy (2015) (1)
- Appropriate treatment strategy for ground glass opacity—dominant non-small cell lung cancer (2018) (1)
- Microwave Breast Imaging Using Rotational Bistatic Impulse Radar for the Detection of Breast Cancer: Protocol for a Prospective Diagnostic Study (2019) (1)
- Certified thoracic surgeons in Japan: a national database survey on risk-adjusted mortality associated with lung resection (2021) (1)
- Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib (2021) (1)
- Clinical significance of 18F-fluorodeoxyglucose-positron emission tomography-positive lymph nodes to outcomes of trimodal therapy for esophageal squamous cell carcinoma. (2018) (1)
- [Extended segmentectomy for small-sized peripheral CN0 non-small cell lung cancer]. (2005) (1)
- A risk model for prolonged air leak after lobectomy using the National Clinical Database in Japan (2021) (1)
- Abstract P6-02-06: Characteristics of lymphocyte-predominant breast cancer in ultrasound images and their application to diagnostic prediction (2019) (1)
- Laparoscopic Repair and Percutaneous Endoscopic Gastrostomy to Treat Giant Esophageal Hiatal Hernia with Gastric Obstruction: A Case Report. (2015) (1)
- Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomy. (2021) (1)
- Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 36-month results. (2013) (1)
- A Multicenter Study of Complex Segmentectomy Versus Wedge Resection in Clinical Stage 0-IA Non-Small Cell Lung Cancer. (2022) (1)
- Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial. (2023) (1)
- Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer. (2010) (1)
- Preoperative predictors of distant recurrence in patients with clinical stage IA lung adenocarcinoma undergoing complete resection. (2016) (1)
- Interstitial pneumonia and advanced age negatively influence postoperative pulmonary function (2022) (1)
- [A resected case of complete response after treatment with S-1 for recurrent squamous cell carcinoma component of the breast]. (2012) (1)
- The Difference in Maximum Standardized Uptake Value among Lung Adenocarcinomas Located at the Upper and Lower Zone on PET/CT (2015) (1)
- Discrepancy of Computed Tomography Images Between Lung and Mediastinal Windows as a Prognostic Significance in Small-sized Lung Adenocarcinom (2003) (1)
- SRC-homology 2 domain-containing phosphatase 2 (SHP2) in epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma (LUAD). (2020) (1)
- Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502‐A1 (2021) (1)
- Techniques of Minimally Invasive Posterior Basal (S10) Segmentectomies of the Lower Lobes (2022) (1)
- A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy (EPP) and postoperative hemithoracic radiation (H-RT) for malignant pleural mesothelioma (MPM): First all-Japan trial. (2013) (1)
- Impact of postoperative pleurodesis on pulmonary function after lung segmentectomy (2020) (1)
- Invasive ductal carcinoma of the pancreas showing exophytic growth. (2009) (1)
- Is cancer history really an exclusion criterion for clinical trial of lung cancer? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery (2016) (1)
- Abstract P6-07-26: Prognostic significance of the maximal value of the baseline standardized uptake value on fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for predicting pathologic malignancy of operable breast cancer with neoadjuvant chemotherapy (2012) (1)
- Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non-small cell lung cancer. (2021) (1)
- [Radical segmentectomy]. (2014) (1)
- Ultrasonography Combined With Contrast-enhanced Ultrasonography Can Predict Lymphocyte-predominant Breast Cancer. (2021) (1)
- 9032 POSTER A Feasibility Study of Induction Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy (EPP) and Postoperative Hemithoracic Radiation (H-RT) for Malignant Pleural Mesothelioma (MPM) – First All Japan Trial (2011) (1)
- Implication of DNA Methylation Profiling in Oral Epithelium forLung Cancer Screening (2012) (1)
- The ratio of CD8+ lymphocytes to tumor-infiltrating suppressive FOXP3+ effector regulatory T cells is associated with treatment response in invasive breast cancer (2022) (1)
- Study of parvociclib administration patients at our hospital (2019) (1)
- Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report (2021) (1)
- Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size (2021) (1)
- Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography. (2020) (1)
- Impact of the Amount of Preoperative Erector Spinae Muscle in Stage I Non-Small Cell Lung Cancer. (2022) (1)
- Microwave Breast Imaging Using Rotational Bistatic Impulse Radar for the Detection of Breast Cancer: Protocol for a Prospective Diagnostic Study (Preprint) (2019) (1)
- The differences in histological changes among pulmonary vessels divided with an energy device. (2018) (1)
- Anatomical location and number of metastatic lymph nodes for prognosis of non-small cell lung cancer (2021) (1)
- Recurrent esophageal adenocarcinoma derived from ectopic gastric mucosa: A case report (2022) (1)
- Prognostic role of interstitial pneumonia with or without emphysema in patients with clinical stage I lung cancer. (2021) (1)
- Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma. (2021) (1)
- Blood biomarkers as predictors of pathological lymph node metastasis in clinical stage T1N0 esophageal squamous cell carcinoma. (2022) (1)
- Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010) (2022) (1)
- [Radical sublobar resection via hybrid video-assisted thoracic surgery (VATS) for small-sized non-small cell lung cancer]. (2006) (1)
- Reply to ‘MUC4 staining in sarcomatoid carcinomas’ by Berg et al. (2018) (1)
- A novel approach to pseudopodia proteomics: excimer laser etching, two-dimensional difference gel electrophoresis, and confocal imaging. (2014) (1)
- Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant Mesothelioma. (2022) (1)
- [Adjuvant surgery for advanced gastric cancer]. (2010) (1)
- Thoracoscopic double-flap reconstruction for esophagogastric junction cancer: A case report (2020) (1)
- Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma (2022) (1)
- [BRONCHOPLASTY FOR LUNG CANCER]. (2016) (1)
- Utility of lymphatic invasion status for the prognosis of early non-small-cell lung cancer (2014) (1)
- Oncological outcome of segmentectomy for early-stage non-small-cell lung cancer with invasive characteristics: a multicentre study. (2022) (1)
- PIT-1: Randomized phase II trail of pemetrexed-cisplatin plus bevacizumab or concurrent thoracic radiation therapy followed by surgery in stage IIIA (N2) nonsquamous non-small cell lung cancer. (2020) (1)
- Effects of Neoadjuvant Chemoradiotherapy on Postoperative Morbidity and Mortality Associated with Esophageal Cancer (2012) (1)
- Dedicated breast PET to improve clinical diagnosis of breast cancer: Initial evaluation. (2017) (1)
- New noncontact sensor for detecting pulmonary tumors during video-assisted thoracic surgery. (2017) (1)
- Resection of primary lung carcinomas by Video-assisted Thoracic Surgery via a card-sized access thoracotomy (2003) (1)
- Predicting the presence of breast cancer using circulating small RNA in the serum (2019) (1)
- A feasibility study of induction pemetrexed plus cisplatin followed by pleurectomy/decortication for malignant pleural mesothelioma (Japan Mesothelioma Interest Group 1101 Trial). (2019) (1)
- Neutrophil-to-Lymphocyte Ratio as a Predictor of Postoperative Recurrence and Prognosis in Oesophageal Squamous Cell Carcinoma (2022) (1)
- Novel technique for identification of the pulmonary intersegmental plane using manual jet ventilation during pulmonary segmentectomy (2020) (1)
- Soluble Mesothelin-related Peptides (SMRP) as a Biomarker for Malignant Pleural Mesothelioma (2009) (1)
- A phase II feasibility study of preoperative chemotherapy with bevacizumab for resectable stage II/IIIA non-squamous non-small cell lung cancer. (2015) (1)
- [Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 1. Surgery, sublobar resection and adjuvant and neoadjuvant therapy for non small cell lung cancer]. (2014) (1)
- Current clinical trials with non-coding RNA-based therapeutics in malignant diseases: A systematic review (2023) (0)
- Abstract P5-03-04: The role of lung biopsy in the management of lung nodules in breast cancer patients (2015) (0)
- Is cancer history really an exclusion criterion for clinical trial of lung cancer? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery. (2017) (0)
- The Impact of Preoperative Diffusing Capacity on Prediction of Postoperative Life-Threatening Complications and Long-term Survival in Clinical Stage I Non-small Cell Lung Cancer (2016) (0)
- Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil. (2013) (0)
- Biomarker analysis of WJOG4107, a randomized phase II trial of adjuvant chemotherapy with S-1 versus CDDP+S-1 for resected stage II-IIIA non-small cell lung cancer (NSCLC). (2013) (0)
- Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma (2023) (0)
- Prognosis of non-small cell lung carcinoma in patients with previous gastric cancer. (2014) (0)
- P1.03-022 Possibility of FDG-PET Predicting the Clinicopathological Characteristics and Prognosis of Lung Adenocarcinoma: Multicenter Study: Topic: Radiology (2017) (0)
- Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer (2022) (0)
- Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition (2023) (0)
- Abstract P1-15-03: Prevention of letrozole–induced bone loss using risedronate in postmenopausal women with hormone receptor positive breast cancer: A multicenter randomized clinical trial (2016) (0)
- Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma (2022) (0)
- ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection (2020) (0)
- Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer (2020) (0)
- Abstract P4-01-04: Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer: Usefulness for malignant grade of triple-negative breast cancer (2013) (0)
- P1.05-056 Increased Risk of Postoperative Recurrence in EGFR-Positive Stage IA to IB Invasive Lung Adenocarcinoma: Topic: Recurrence (2017) (0)
- Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominance (2023) (0)
- Utility of dedicated breast positron emission tomography as a tool for predict malignancy grade and staging of breast cancer. (2018) (0)
- Prospective randomized crossover study of effects of traditional Japanese herbal medicine rikkunshito on food intake and plasma acylated ghrelin levels in patients with esophageal cancer administered with cisplatin-based chemotherapy. (2017) (0)
- OP-ICVA220012 1..7 (2022) (0)
- Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma (2015) (0)
- The efficacy of thoracoscopic surgery for descending necrotizing mediastinitis (2023) (0)
- The relationship between the malignancy grade of lung adenocarcinoma with micropapillary pattern and the findings of positron emission tomography (2015) (0)
- Commentary: Segmentectomy as a standard surgery, a new era in small sized, peripheral, non–small cell lung cancer (2022) (0)
- P2.15-011 Therapeutic Strategies and Genetic Comparisons in SCLC and LCNEC of the Lung Using Next-Generation Sequencing (2017) (0)
- P2.03-45 PKCι-PAK1 Pathway Modulates Sensitivity to Therapy in EGFR, KRAS Mutant Adenocarcinoma and Squamous Cell Carcinoma (2019) (0)
- Oncologic outcomes of segmentectomy versus lobectomy for radiologically aggressive small-sized lung cancer. (2019) (0)
- Detectability of Breast Tumor by a Hand-held Impulse-Radar Detector: Performance Evaluation and Pilot Clinical Study (2017) (0)
- OA15.03 Comparison of Prognosis between Lobectomy and Sublobar Resection for Clinical Stage I Non-Small Cell Lung Cancer with Interstitial Lung Disease (2017) (0)
- Brightness analysis in contrast-enhanced ultrasound using sonazoid for breast cancer. (2013) (0)
- ASO Visual Abstract: S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial (2022) (0)
- P1.17-08 mRNA Expression Level of Receptor Tyrosine Kinases and Non-Receptor Tyrosine Kinases as a Recurrence Risk in Resected Adenocarcinoma of the Lung (2019) (0)
- A phase III, randomized, double-blind, multicenter, active control study of fosnetupitant for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving cisplatin-based highly emetogenic chemotherapy (HEC): CONSOLE. (2021) (0)
- The tumor-infiltrating effector regulatory T cell:CD8+ lymphocyte ratio in invasive breast cancer (2019) (0)
- Abstract P4-09-17: Wnt5a expression is associated with high-grade malignancy in ER-positive breast cancer (2016) (0)
- 1187PCOMPARISON OF MALIGNANT GRADES BETWEEN PURE AND PARTIALLY INVASIVE TYPES OF CLINICAL STAGE IA LUNG ADENOCARCINOMA. (2014) (0)
- Commentary: Aspects of epidermal growth factor receptor status: Prognostic factor versus predictive factor. (2020) (0)
- Prognostic significance of the maximal value of the baseline standardized uptake value on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography for predicting pathologic malignancy of operable breast cancer. (2013) (0)
- Late Critical Complications After Surgery Following Induction Chemoradiotherapy for Lung Cancer (2003) (0)
- Technical feasibility and cosmetic advantage of hybrid endoscopy-assisted breast-conserving surgery. (2013) (0)
- S2-3 Clincal importance of controlling vomiting/nausea induced by chemotherapy for cancer(SYMPOSIUM 2: THE MECHANISMS INVOLVED IN EMESIS ASSOCIATED WITH VARIOUS DRUGS)(Proceedings of the 31st Annual Meeting) (2004) (0)
- Predictive factors of distant recurrence after surgery in patients with clinical stage IA lung adenocarcinoma. (2013) (0)
- FP01.04 Prospective Observational Study of Activities of Daily Livings in Elderly Patients After Lung Cancer Surgery (JCOG1710A) (2021) (0)
- A multi-institutional feasibility study of induction pemetrexed (Pem) plus cisplatin (Cis) followed by extrapleural pneumonectomy (EPP) and postoperative hemithoracic radiation (RT) for malignant pleural mesothelioma (MPM): Japan Mesothelioma Research Center (JMRC) 001001 trial. (2010) (0)
- 229PDedicated breast PET to predict pathological complete response after neoadjuvant chemotherapy for breast cancer (2017) (0)
- 25P A non-pathway-specific approach in EGFR and KRAS mutant or squamous cell histology non-small cell lung cancer (NSCLC) (2018) (0)
- Reply to Zhang et al. (2020) (0)
- P2.06-037 A Feasibility Study of Concurrent Chemoradiation Followed by Surgery for Pathologically-Proven Clinical IIIA-N2 Non-Small Cell Lung Cancer: Topic: Radiotherapy, TT Fields (2017) (0)
- 3028 A feasibility study of adjuvant chemotherapy with weekly nab-paclitaxel and carboplatin for completely resected non-small cell lung cancer (2015) (0)
- PS02.065: UTILITY OF FDG-PET TO PREDICT LONG TERM PROGNOSIS FOR PATIENTS WITH ESOPHAGEAL CANCER RECEIVING NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY SURGERY (2018) (0)
- Successful Management of Esophageal Cancer With Perforation Using Bypass Surgery Followed by Definitive Chemoradiotherapy (2020) (0)
- P1.17-09 Surgical Outcomes of Complex Versus Simple Segmentectomy for Stage I Non-Small Cell Lung Cancer (2019) (0)
- PO-0686: A feasibility study of induction CDDP/MTA followed by EPP and postoperative hemithoracic radiation therapy for MPM (2014) (0)
- Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness (2022) (0)
- P1.05-051 Safety and Compliance Data of the Phase III Study of Adjuvant Chemotherapy in Completely Resected P-Stage I Non-Small Cell Lung Cancer: JCOG0707: Topic: Neoadjuvant and Adjuvant Chemotherapy (2017) (0)
- 74PFebrile neutropenia and primary prophylactics in docetaxel plus cyclophosphamide chemotherapy for breast cancer: A Japanese institution experience (2017) (0)
- Title Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line (2017) (0)
- Abstract P2-03-07: Prediction of the pathological response to neoadjuvant chemotherapy in patients with breast cancer using sonazoid-enhanced ultrasonography (2013) (0)
- P1.02-002 Diagnostic Utility of MUC4 Expression to Differentiate Epithelioid Mesothelioma from Lung Adenocarcinoma and Squamous Cell Carcinoma (2017) (0)
- Abstract 1402: Preclinical evaluation of a novel senescence-associated miRNA miR-3140-3p for malignant pleural mesothelioma (2020) (0)
- The TILs-US score on ultrasonography can predict the pathological response to neoadjuvant chemotherapy for human epidermal growth factor receptor 2-positive and triple-negative breast cancer. (2022) (0)
- Reply to “Lobe-Specific Lymph Node Dissection for Lung Cancer: Is It Still Feasible?” by Han-Yu Deng (2021) (0)
- The Efficacy of PCSK9 Inhibitors in Treating Hypercholesterolemia Caused by Lorlatinib: A Report of Two Cases. (2023) (0)
- P1.13-13 High-Risk Clinical Stage I Non-Small Cell Lung Cancer Based on High-Resolution Computed Tomography Findings (2019) (0)
- Pleural Biopsy for a Definitive Diagnosis of Malignant Pleural Mesothelioma (2010) (0)
- MRI EXAMINATION ON MICROCALCIFICATION LESIONS ON MAMMOGRAPHY (2010) (0)
- Reply to Sanz-Santos et al. (2023) (0)
- Proposals and challenges of lecture to high school girls, aiming to spread of correct knowledge and improve screening rate of breast cancer (2019) (0)
- Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma (2023) (0)
- Reply to Li and Che. (2019) (0)
- The intersegmental pulmonary vein is not always located on the intersegmental plane of the lung: Evaluation with 3-dimensional volume-rendering image reconstruction (2022) (0)
- Value of FDG-PET/CT findings revised using an anthropomorphic body phantom for the evaluation of tumor malignancy grade in small-sized lung adenocarcinomas: A multicenter study. (2016) (0)
- The safety and efficacy of fibrinogen and thrombin-based collagen fleece for treatment of pleural injury (2015) (0)
- Prediction of lymph node metastasis using 5-point visual scale criteria of [18F]-fluoro-2-deoxy-D-glucose on positron emission tomography / computed tomography for early stage lung adenocarcinoma. (2020) (0)
- THYMIDYLATE SYNTHASE, DIHYDROPYRIMIDINE DEHYDROGENASE, AND OROTATE PHOSPHORIBOSYLTRANSFERASE PROTEIN EXPRESSION IN ESOPHAGEAL CANCER PATIENTS: CORRELATION WITH CLINICOPATHOLOGICAL FACTORS AND PROGNOSIS (2008) (0)
- MA01.06 Evaluation of Safety and Efficacy in Surgical Treatment for Octogenarian Lung Cancer Patients by Multicenter Prospective Study: JACS1303 (2018) (0)
- A case report of recurrent catamenial pneumothorax treated with GnRH analogue (2005) (0)
- PS02.192: TWO CASES OF PRIMARY MALIGNANT MELANOMA OF ESOPHAGUS TREATED WITH SUBTOTAL ESOPHAGECTOMY (2018) (0)
- P1.02-052 Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma (2017) (0)
- Pathologic response to predict survival in patients who underwent surgery after neoadjuvant chemotherapy with bevacizumab for clinical stage II/IIIA non-squamous non-small cell lung cancer. (2016) (0)
- Reply to the editor. (2013) (0)
- Psychological states regarding adjuvant chemotherapy in patients with non-small cell lung cancer. (2022) (0)
- A multi-center phase III study of carboplatin/paclitaxel versus oral uracil-tegafur as the adjuvant chemotherapy in resected non-small cell lung cancer (2016) (0)
- Correction to: Risk assessments for broncho-pleural fistula and respiratory failure after lung cancer surgery by National Clinical Database Japan (2019) (0)
- 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography evaluation to predict postoperative outcomes for patient with luminal-type breast cancer. (2014) (0)
- Abstract 2853: Cell motility and invasiveness are promoted by guanylate binding protein 1, GBP-1 in lung adenocarcinoma (2019) (0)
- Role of solid tumor size compared with whole tumor size to predict pathologic malignant grade or prognosis in clinical stage IA lung adenocarcinoma: A multicenter study. (2011) (0)
- MA09.09 EGFR Mutation Status Is a Risk of Recurrence in pN0–1 Lung Adenocarcinoma When Considering pStage and Histological Subtype (2021) (0)
- Corrigendum: Is cancer history really an exclusion criterion for clinical trial of lung cancer? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery [Japanese Journal of Clinical Oncology, (2016)] doi: 10.1093/jjco/hyw157 (2017) (0)
- Discrepancy Between Radiological and Pathological Tumor Size in Early-Stage Non-Small Cell Lung Cancer: A Multicenter Study. (2022) (0)
- Abstract 30: Effect of Wnt5a on aggressiveness of estrogen receptor-positive breast cancer and cancer cell migration through ALCAM pathway (2018) (0)
- Reply to Zhou et al. (2022) (0)
- 446PMulticenter phase II study of cisplatin, pemetrexed, plus bevacizumab followed by maintenance pemetrexed plus bevacizumab for patients with advanced or recurrent non-squamous non-small cell lung cancer: MAP study (2017) (0)
- FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung. (2023) (0)
- Reply to Shanmugan et al. (2005) (0)
- Leukocyte Telomeric G-Tail Length Shortening Is Associated with Esophageal Cancer Recurrence (2022) (0)
- Abstract P2-16-13: Meta-analysis of nanoparticle albumin-bound paclitaxel (Nab-PTX) used as a neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01) (2020) (0)
- Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system (2023) (0)
- Abstract 3661: Notch2 and Six1 are upregulated during progression of early-stage lung adenocarcinoma and define its unfavorable subset at advanced stages (2012) (0)
- 1188PWHAT ARE RADIOGRAPHIC FINDINGS FOR PREDICTING INDOLENT LUNG ADENOCARCINOMA? (2014) (0)
- Surgical Resection of Thoracic Esophageal Cancer with Interstitial Lung Disease: A Case Report. (2016) (0)
- 2225 Prediction of tumor response and survival using 18F-fluorodeoxyglucose PET in trimodality therapy for esophageal squamous cell carcinoma (2015) (0)
- Abstract P6-02-09: Diagnostic performance of dedicated breast PET for the prediction of pathological response after neoadjuvant chemotherapy (2019) (0)
- Risk factors for recurrence of stage I epidermal growth factor receptor mutated lung adenocarcinoma. (2023) (0)
- Effect of Secondary Prophylactic G-CSF on the Occurrence of Febrile Neutropenia in Breast Cancer (2022) (0)
- Segmentectomy for STAS positive lung adenocarcinoma. (2021) (0)
- [Metastases to the mediastinal lymph nodes in a series of two-hundred-consecutive operations for primary lung cancer]. (1991) (0)
- O2-3-5Bevacizumab beyond disease progression in advanced non-squamous NSCLC (WJOG 5910L): a randomized phase II trial (2015) (0)
- The tumor-infiltrating lymphocyte ultrasonography score can provide a diagnostic prediction of lymphocyte-predominant breast cancer preoperatively (2022) (0)
- Validity of the modified RECIST criteria and EORTC PET criteria evaluated based on the pathologic findings for patients with resectable malignant pleural mesothelioma. (2016) (0)
- Abstract P6-03-08: Detection ability of dedicated breast positron emission tomography for small-sized breast cancer (2018) (0)
- Pathologic response and survival after cisplatin, pemetrexed, and bevacizumab followed by surgery for clinical stage II/IIIA non-squamous non-small cell lung cancer (2016) (0)
- A Phase III Study of Adjuvant Chemotherapy in Patients with Completely Resected, Node-Negative Non-Small Cell Lung Cancer (2020) (0)
- Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy. (2022) (0)
- Correction to: Effect of Wnt5a on drug resistance in estrogen receptor‑positive breast cancer (2021) (0)
- Abstract P1-02-08: 18F-fluoro-2-deoxy-glucose positron emission tomography/ computed tomography evaluation shows the utility for predicting postoperative outcomes on Luminal types breast cancer patients (2015) (0)
- Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis (2021) (0)
- [A Case of Breast Metastasis from Renal Cell Carcinoma]. (2022) (0)
- Higher circulatory HMGB1 accelerates postoperative acute exacerbation of interstitial lung disease in lung cancer (2020) (0)
- 3004 Subobar resection choice based on HRCT and FDG-PET/CT findings for clinical stage IA non-small cell lung cancer (2015) (0)
- Prospective Randomized Trial of Early Postoperative Enteral and Total Parenteral Nutrition for Treating Esophageal Cancer (2021) (0)
- Abstract 2577: Circulating micro RNA/isomiRs as novel biomarker of esophageal squamous cell carcinoma (2019) (0)
- Usefulness of serum S100A4 and positron‐emission tomography on lung cancer accompanied by interstitial pneumonia (2022) (0)
- Abstract P3-04-01: Telomere G-tail length correlates with the presence of breast cancer (2020) (0)
- Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma (2023) (0)
- Functional inactivation of CD4+CD25high regulatory T cells using low dose human/mouse chimeric anti-CD25 monoclonal antibody enhanced lymphokine-activated killer cells activity (2008) (0)
- Abstract P6-02-15: TILs-US score using ultrasonography before chemotherapy predicts the outcome of neoadjuvant treatment in HER2 positive breast cancer (2019) (0)
- Tumour Location Predicts Occult N1 Nodal Metastasis in Clinical Stage I Non-small Cell Lung Cancer. (2022) (0)
- Postoperative Exercise Tolerance After Extended Segmentectomy-Analysis Based on a Conventional Treadmill Test- (2003) (0)
- HIJM 585 Induction of ybT Cells Using Zoledronate Plus Interleukin-2 in Patients with Metastatic Cancer (2013) (0)
- Clinical Test of Surface Rejection Method for Microwave Breast Cancer Imaging (2021) (0)
- Comparison of prognostic impact between metabolic and radiologic response after induction chemotherapy for resectable malignant pleural mesothelioma: A multicenter study. (2012) (0)
- Abstract P2-03-08: Usefulness of sonazoid-enhanced ultrasonography in the evaluation of the biological features of breast cancer (2013) (0)
- Abstract 2490: Novel application for pseudopodial proteomics using excimer laserablation and two-dimensional difference gel electrophoresis. (2013) (0)
- Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma (2022) (0)
- Abstract 5594: Inmune gene expression by nCounter in mucinous adenocarcinoma lung cancer (2020) (0)
- RIGHT UPPER BRONCHUS TRANSECTION CAUSED BY BLUNT CHEST TRAUMA (1990) (0)
- ASO Author Reflections: Survival Outcomes between Patients with Hypermetabolic Non-small Cell Lung Cancer Undergoing Systematic and Lobe-Specific Mediastinal Lymph Node Dissection (2021) (0)
- Abstract P6-02-11: The TILs-US scores based on ultrasonography can predict lymphocyte-predominant breast cancer before surgery (2019) (0)
- Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy (2022) (0)
- ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy? (2021) (0)
- Minimally Invasive Surgery for Giant Oesophageal and Gastric Leiomyomas (2018) (0)
- Abstract P4-02-06: Evaluation of contrast-enhanced ultrasonography for early prediction of response to neoadjuvant chemotherapy in triple negative breast cancer (2017) (0)
- Association between [F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer (2015) (0)
- Reply to the editor. (2014) (0)
- P211 High SUV max of 18f FDG-PET/CT is significantly associated with poor outcome in operable breast cancer (2011) (0)
- 391PStealth breast cancer on ring-type dedicated breast PET (2017) (0)
- Aminopeptidase N / CD 13 as a Potential Therapeutic Target in Malignant Pleural Mesothelioma (2018) (0)
- MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung (2018) (0)
- MA06.06 A Phase III Study of Adjuvant Chemotherapy in Patients with Completely Resected, Node-Negative Non-Small Cell Lung Cancer (2019) (0)
- Segmentectomy for clinically early‐stage primary squamous cell carcinoma of the lung (2022) (0)
- Abstract P6-02-17: Hand-held impulse-radar detector for breast cancer: development and a pilot study (2019) (0)
- Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5- fl uorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma (2018) (0)
- 9011 ORAL Multicenter Analysis of High-resolution Computed Tomography and Fluorodeoxyglucose-positron Emission Tomography/Computed Tomography to Predict Malignant Grade of Clinical Stage IA Lung Adenocarcinoma (2011) (0)
- PO104 THE SURGICAL MANAGEMENT OF LUNG NODULES IN BREAST CANCER PATIENTS (2015) (0)
- Invited commentary. (2009) (0)
- [Dawn of Radical Segmentectomy for Small Sized Peripheral Non-small Cell Lung Cancer]. (2023) (0)
- Metachronous Lung Cancer After Pleurectomy/Decortication. (2019) (0)
- Surgery for Local Recurrence After Complete Response Had Been Obtained by Chemoradiotherapy for Small Cell Lung Cancer (2006) (0)
- Long-term Outcome of Patients with Peripheral Ground Glass Opacity Dominant Lung Cancer after Sublobar Resections (2023) (0)
- 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Tumor Immune Microenvironment Function in Early Triple-negative Breast Cancer (2022) (0)
- 9033 Multicenter evaluation of malignancy in small-sized lung adenocarcinomas: revision of variations among institutions and underestimation generated by tumor size on PET/CT values using a phantom study (2009) (0)
- 1181PDMAXIMUM STANDARDIZED UPTAKE VALUES ON POSITRON EMISSION TOMOGRAPHY CORRELATES WITH IASLC/ATS/ERS HISTOLOGIC SUBTYPES AND PROGNOSIS OF CLINICAL STAGE IA LUNG ADENOCARCINOMA. (2014) (0)
- Subcutaneous total glandectomy for gynecomastia using endoscopic assistance and tumescent technique (2010) (0)
- Abstract PS19-23: Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer (2021) (0)
- P2.09-008 Usefulness of Immunohistochemistry in the Differential Diagnosis of Epithelioid Mesothelioma and Lung Squamous Cell Carcinoma (2017) (0)
- Reply to Altundag et al. (2005) (0)
- Preoperative predictors of distant recurrence in patients with clinical stage IA lung adenocarcinoma undergoing complete resection (2016) (0)
- Combined Diagnosis Of Three-dimensional Computed Tomography And Three- Dimensional Computed Tomography Lymphography, And Three-dimensional Virtual Navigation Biopsy Of Sentinel Lymph Node In Patients With Early Breast Cancer (2011) (0)
- Malignant prediction of incidental findings using ring-type dedicated breast positron emission tomography (2022) (0)
- Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery (2022) (0)
- Therapeutic value of postmastectomy radiation therapy for T1–2 breast cancer with 1–3 positive lymph nodes (2019) (0)
- Ring-like uptake appearance on dedicated breast positron emission tomography before chemotherapy predicts outcome of neoadjuvant chemotherapy in breast cancer (2019) (0)
- FP12.03 SRC-Homology 2 Domain-Containing Phosphatase 2 (SHP2) in Resected Lung Adenocarcinoma (LUAD) (2021) (0)
- Malignant prediction of incidental findings using ring-type dedicated breast positron emission tomography (2022) (0)
- Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma (2023) (0)
- Preoperative cumulative smoking dose on lung cancer surgery in a Japanese nationwide database. (2021) (0)
- Reply to the editor. (2013) (0)
- Is cancer history really an exclusion criterion for clinical trial of lung cancer? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery. (2016) (0)
- [Double-sleeve lingual segment resection]. (2013) (0)
- O1-1 Second-line tislelizumab vs chemotherapy in advanced or metastatic ESCC: RATIONALE 302 Japanese subgroup (2022) (0)
- O-056A LUNG CANCER SURGERY RISK MODEL OF 78 594 CASES FROM 2014 TO 2015 IN A JAPANESE NATIONWIDE WEB-BASED DATABASE (2017) (0)
- P3-07-27: ROCK II Expression Can Be a Potential Marker of Non-Sentinel Lymph Node Metastasis in Breast Cancer Patients with Sentinel Lymph Node Involvement. (2011) (0)
- Segmentectomy preserves better immune-nutritional status than lobectomy in patients with early-stage lung cancer. (2023) (0)
- A Resected Case of Pulmonary Adenosquamous Cell Carcinoma Developed from a Scar Formed After Chemoradiation Therapy for Small Cell Lung Carcinoma (2011) (0)
- Segmentectomy and wedge resection should be distinguished as sublobar resections for lung cancer. (2023) (0)
- Neoadjuvant chemotherapy with bevacizumab followed by surgery for clinical stage II/IIIA non-squamous non-small cell lung cancer: Survival results from a phase II feasibility study (NAVAL). (2018) (0)
- Sublobar resection for non-small-cell lung cancer in octogenarians: a prospective, multicenter study. (2023) (0)
- The clinical significance of increase in SUVmax at delayed phase on 18F-FDG PET/CT scan in patients with early stage breast cancer. (2016) (0)
- P2.03-14 PKCi-PAK1 Pathway Modulates Sensitivity to Therapy in EGFR, KRAS Mutant and Squamous Cell Non-Small Cell Lung Cancer (NSCLC) (2018) (0)
- 210PDedicated breast PET for predicting residual disease after breast cancer neoadjuvant chemotherapy (2017) (0)
- Effect of Wnt5a on aggressiveness of ER-positive breast cancer and cancer cell migration through JNK-ALCAM pathway. (2017) (0)
- Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations. 2000. (2009) (0)
- Abstract P1-02-04: Impact of perflubutane-enhanced ultrasonography for evaluating malignancy grade of breast cancer (2015) (0)
- Wedge resection with omission of lymph node dissection as an optional treatment strategy in octogenarians or older with early stage non-small cell lung cancers (2019) (0)
- ASO Author Reflection: Position of the Complex Segmentectomy on Postoperative Pulmonary Function (2021) (0)
- P2.17-01 Analysis of Clinical Features and Prognosis of Non-Small Cell Lung Cancer Exceeding 30 mm Depending on the Ground Glass Opacity (GGO) Ratio (2019) (0)
- MA10.11 Sensitivity and Optimal Clinicopathological Features of Genetic Targeted Liquid Biopsy in pN0M0 Lung Adenocarcinoma (2019) (0)
- Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3 (2022) (0)
- PIT-2: A multicenter phase II trail of S-1 plus cisplatin with concurrent radiotherapy followed by surgery in stage IIIA (N2) lung squamous cell carcinoma. (2021) (0)
- P2.05-011 Segmentectomy versus Wedge Resection in Patients with Clinical Stage I Non-Small Cell Lung Cancer Who Were Unfit for Lobectomy (2017) (0)
- Completion lobectomy for unanticipated pN1 disease on postoperative pathology after segmentectomy for cT1N0 lung cancer: Prevention of pleural adhesion by using fibrin glue (2015) (0)
- [Current status and future direction of Japan's clinical trial for malignant pleural mesothelioma]. (2011) (0)
- 6527 POSTER Post- Chemoradiotherapy Standardized Uptake Value of FDG-PET as a Significant Predictor of Survival After Subsequent Surgery in Multimodality Treatment for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (2011) (0)
- Preoperative diffusing capacity correlates with tumor malignant grade and surgical outcome in clinical stage I lung cancer (2016) (0)
- 6518 POSTER Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer – Analysis of Pattern of Recurrence and Prognostic Factors for Survival (2011) (0)
- Complications and Survival After Lung Cancer Resection in Interstitial Lung Disease. (2022) (0)
- Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma (2019) (0)
- [Archives of "comprehensive approach on asbestos-related diseases" supported by the "special coordination funds for promoting science and technology (H18-1-3-3-1)"-- overview of group research project, care and specimen registration, cellular characteristics of mesothelioma and immunological effects (2011) (0)
- IPA-3 (PAK1 inhibitor) or OTSSP167 (MELK inhibitor) plus auranofin (PKCι inhibitor), a therapeutic option for EGFR mutant, KRAS mutant and squamous cell non-small cell lung cancer (NSCLC). (2018) (0)
- Optimal Technique in Combined Application of Fibrin Glue and Polyglycolic Acid Felt for Alveolar Air Leakage: An Experimental Study (2011) (0)
- Utility of Blood Biomarkers as a Predictor of Pathological Lymph Node Metastasis in Clinical Stage T1N0 Esophageal Squamous Cell Carcinoma (2021) (0)
- S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial (2022) (0)
- The intracellular domain of cell adhesion molecule 1 is present in emphysematous lungs and induces lung epithelial cell apoptosis (2015) (0)
- 3029 Role of lepidic component in adjuvant chemotherapy for stage I lung adenocarcinoma: A propensity-score matching analysis (2015) (0)
- Nomenclature of Segments (2012) (0)
- Histology and detectability on ring-type dedicated breast PET in breast cancer. (2018) (0)
- P2.16-11 Prognostic Role of Combined Pulmonary Fibrosis and Emphysema (CPFE) in Patients with Clinical Stage I Lung Cancer (2018) (0)
- Overall Survival Analysis of Bevacizumab Plus Erlotinib for Advanced EGFR-Mutant Metastatic NSCLC (2021) (0)
- Usefulness of Serum S100A4 and PET on Lung Cancer Accompanied with Interstitial Pneumonia (2022) (0)
- 27 – Results of Video-Assisted Techniques for Resection of Lung Cancer (2018) (0)
- FP14.02 A Phase II Study of Osimertinib versus Combination of Osimertinib and Chemotherapy for EGFR and T790M-Mutation Positive NSCLC (2021) (0)
- Prospective, multicenter study of pleural adhesion in repeated pulmonary surgery (2015) (0)
- Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm. (2020) (0)
- A Multiinstitutional Feasibility Study of Trimodality Therapy for Resectable Malignant Mesothelioma (2009) (0)
- Expression of Hypoxia-Induced Factor 1α and Glucose Transporter 1 Correlates with [18F]-Fluoro-2-Deoxy-Glucose Uptake on Positron Emission Tomography and Tumor Aggressiveness in Different Histologic Subtypes of Lung Adenocarcinomas (2012) (0)
- Role of FDG-PET/CT in prediction of pathological tumor response and survival after trimodality therapy for esophageal squamous cell carcinoma (2015) (0)
- P1.17-13 Next Generation Sequencing of the Circulating Small RNA from Serum Identifies Small RNA-Based Biomarker Panel for Stage I-II Lung Adenocarcinoma (2019) (0)
- 1192PINFLUENCE OF GASTROINTESTINAL TRACT CANCER HISTORY ON THE OUTCOMES OF LUNG CANCER SURGERY: EXTENDED INCLUSION CRITERIA FOR CLINICAL TRIALS. (2014) (0)
- Abstract P5-02-03: Evaluation of pathological malignancy grade and neoplastic progress of breast cancer using dedicated breast positron emission tomography (2018) (0)
- P-129DOES THE HISTOLOGICAL SUBTYPE OF ADENOCARCINOMA INFLUENCE THE EXTENT OF RESECTION IN PATIENTS WITH CLINICAL STAGE IA ADENOCARCINOMA? (2014) (0)
- Role of the Tumor-suppressor TSLC1 (Tumor Suppressor in Lung Cancer 1) Gene as a Prognostic Factor in Lung Adenocarcinom (2003) (0)
- 9125 Can the modified RECIST criteria and EORTC PET criteria predict the postoperative pathologic findings for resectable malignant pleural mesothelioma following neoadjuvant chemotherapy (2009) (0)
- Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study (2018) (0)
- Reduction rate of the maximal value of the baseline standardized uptake value on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography to predict response of breast cancer to neoadjuvant chemotherapy. (2014) (0)
- P1.17-01 Surgical Outcome of Early Stage Lung Cancer Related vs Unrelated to Honeycomb Lesions with Interstitial Pneumonia (2019) (0)
- 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts the Function of Tumor Immune Microenvironment in Early Triple-Negative Breast Cancer (2021) (0)
- Classification of abnormal findings on ring-type dedicated breast PET for detecting breast cancer (2019) (0)
- Attempts at assisted reproductive medical intervention in breast cancer patients who desire fertility preservation. (2018) (0)
- Feasibility of repeated ipsilateral anatomical pulmonary resection (2022) (0)
- Prognostic Factors for Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery (2022) (0)
- Results of neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fuluorouracil for advanced esophageal cancer. (2018) (0)
- Abstract P1-02-04: Contrast-enhanced ultrasonography after two cycles of chemotherapy predicts the outcome of neoadjuvant chemotherapy in triple-negative breast cancer (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Morihito Okada?
Morihito Okada is affiliated with the following schools:
